[Skip to Navigation]
May 1967

Comparative Acute Toxicity of Four Drugs: A Study of Neomycin, Gentamicin, Kanamycin, and Dihydrostreptomycin

Author Affiliations

Salt Lake City

From the Division of Infectious Diseases, Department of Internal Medicine, University of Utah College of Medicine and Salt Lake County General Hospital, Salt Lake City. Dr. Watanabe is presently at the University of Hokkaido, Sapporo, Japan. Dr. Parker is presently at the Northwestern University School of Medicine, Chicago.

Arch Intern Med. 1967;119(5):493-502. doi:10.1001/archinte.1967.00290230131004

Of the complex aminosugar antibiotics, streptomycin-dihydrostreptomycin, neomycin, kanamycin, and gentamicin have attained to some degree of clinical application. Kanamycin and gentamicin are reported to rival neomycin in antibacterial potency,1 without partaking so generously of its toxic properties. However, careful comparison of these agents, taking into account the critical differences in molecular weight, apparently has not been carried out.

This report presents the results of side-byside comparisons of equimolar quantities of neomycin, kanamycin, gentamicin, and dihydrostreptomycin with regard to (1) toxicity for bacteria, ie, in vitro antibacterial activity against 246 clinical isolates of gramnegative bacilli; and (2) toxicity for mammalian cells, ie, acute, lethal toxicity to Swiss-Webster albino mice on injection intravenously, intraperitoneally, or intramuscularly.

These experiments were concerned with acute toxicity. Consequently, the known, late-appearing, differences in otovestibular toxicity of streptomycin-dihydrostreptomycin2 were not relevant. Dihydrostreptomycin, as a chemical derivative of streptomycin, is available in higher purity than is

Add or change institution